Electronic atomizer output self-protection control method, system and product

Abstract

The invention relates to the technical field of electronic atomizer output self-protection, and particularly discloses an electronic atomizer output self-protection control method and system and a product, and the method comprises the following steps: 1, when an electronic atomizer is used, obtaining user inspiration behavior data, processing the data, and calculating to obtain a use abnormity judgment coefficient; wherein the inspiration behavior data comprises an inspiration force value and an inspiration duration value of the user; 2, comparing the use abnormity judgment coefficient with a use abnormity judgment coefficient threshold value, and if the use abnormity judgment coefficient is larger than the use abnormity judgment coefficient threshold value, generating an inspiration behavior abnormal signal; and step 3, based on the generated inspiration behavior abnormal signal. Therefore, whether the inspiration behavior is abnormal or not can be judged through comprehensive calculation of the inspiration behavior, whether the inspiration behavior of a user is abnormal or not can be known in time, and powerful guarantee is provided for safety of the user and stability of a product.

Description

Technical Field

[0001] The present invention relates to the technical field of electronic atomizer output self-protection, and in particular to a control method, system and product for electronic atomizer output self-protection. Background Art

[0002] Electronic atomizer is the so-called electronic cigarette, the former name of healthy electronic cigarette; the biggest difference between it and traditional cigarettes is that it does not go through combustion, does not contain toxic substances such as tar, carbon monoxide, nitrite, etc., and does not have second-hand smoke that has a great impact on people around; the structure of the electronic atomizer is a heating component, which is powered by a battery to generate heat, so that the smoke oil next to it evaporates and forms smoke, so that people can achieve the effect of "smoking" when they inhale; The Chinese invention patent with publication number CN114089681B discloses a control method, system and product for self-protection of electronic atomizer output, wherein an abnormal monitoring mechanism is added to the logic control unit so that the chip can judge the abnormal situation. After the chip outputs and drives to timeout multiple times, the output is stopped and the intelligent detection unit is turned off to avoid overheating or even spontaneous combustion of the load due to long-term output driving of the external load in extreme situations, thereby avoiding the risk of spontaneous combustion and greatly improving the safety of the electronic atomizer; However, there are still the following shortcomings. When the electronic vaporizer is used to monitor inhalation abnormalities, the monitoring data is relatively single, and part of the multi-dimensional comprehensive judgment of the inhalation behavior data is lacking. At the same time, it is impossible to judge the degree of abnormality of the inhalation behavior. When the abnormality level is high, the electronic vaporizer can be analyzed and responded to in a timely manner, which causes certain safety risks and damages to the use of the electronic vaporizer. Summary of the invention

[0003] The object of the present invention is to provide a control method, system and product for self-protection of electronic atomizer output, so as to solve the technical problems in the above background.

[0004] The purpose of the present invention can be achieved through the following technical solutions: In a first aspect, the present invention provides a control method for self-protection of electronic atomizer output, comprising the following steps: step one: when using the electronic atomizer, obtaining the user's inhalation behavior data, processing the data, and calculating the use abnormality judgment coefficient; wherein the inhalation behavior data includes the user's inhalation force value and the inhalation duration value; step two: comparing the use abnormality judgment coefficient with the use abnormality judgment coefficient threshold, if the use abnormality judgment coefficient is greater than the use abnormality judgment coefficient threshold, generating an inhalation behavior abnormality signal; step three: based on the generated inhalation behavior abnormality signal, calculating an abnormality degree assessment value of the monitoring period; comparing the abnormality degree assessment value with the abnormality degree assessment threshold, if the abnormality degree assessment value is greater than the abnormality degree assessment threshold, generating a high abnormality degree signal; step four: based on the generation of the high abnormality degree signal, analyzing the stability of the abnormal inhalation behavior during the monitoring period.

[0005] As a further solution of the present invention: the process of obtaining the abnormality judgment coefficient is as follows: The acquisition process of using the abnormality judgment coefficient is as follows: Obtain the inhalation force deviation ratio PC and duration ratio ZB; The obtained duration ratio ZB and inhalation force deviation ratio PC are processed by the formula: , calculate the abnormal use judgment coefficient PD for each inhalation, and a1 and a2 are preset proportional coefficients.

[0006] As a further solution of the present invention: the process of obtaining the duration ratio value is as follows: When using the electronic atomizer, a monitoring period is preset, and during the monitoring period, the inhalation force value of each inhalation is obtained, and the inhalation force value is compared with the preset inhalation force value; If the inhalation force value is greater than the preset inhalation force value, an inhalation abnormality signal is generated; The duration of the abnormal inhalation signal is monitored in real time, and the duration corresponding to the duration of the abnormal inhalation signal is ratioed to the duration corresponding to the monitoring period to obtain a duration ratio value, which is marked as ZB.

[0007] As a further solution of the present invention: the process of obtaining the inhalation force deviation ratio is: Mark the time period when the abnormal inhalation signal appears as the abnormal inhalation period, obtain the inhalation force value in the abnormal inhalation period, perform difference processing on the inhalation force value and the preset inhalation force value to obtain the inhalation force difference in the abnormal inhalation period, sum and average all the inhalation force differences in the abnormal inhalation period to obtain the inhalation force difference mean, perform ratio processing on the inhalation force difference mean and the preset inhalation force value to obtain the inhalation force deviation ratio, and mark it as PC; As a further solution of the present invention: the process of obtaining the abnormality evaluation value is as follows: Obtain the percentage of abnormal inhalation behavior times and the mean of abnormal inhalation behavior deviation ratio; Substitute into the formula , the abnormality evaluation value CD is calculated, where CS represents the ratio of abnormal inhalation behavior times, PY represents the mean deviation ratio of abnormal inhalation behavior, and s1 and s2 are preset proportional coefficients.

[0008] As a further solution of the present invention: the process of obtaining the abnormal inhalation behavior frequency ratio and the abnormal inhalation behavior deviation ratio mean is: During the monitoring period, the total number of times the user inhales and the number of times abnormal inhalation behavior signals are generated are obtained, and the number of times abnormal inhalation behavior signals are generated is processed by ratio processing with the total number of inhalations to obtain the ratio of the number of abnormal inhalation behavior times; Obtain the usage abnormality judgment coefficient corresponding to the generated inhalation behavior abnormal signal, calculate the difference between the usage abnormality judgment coefficient and the usage abnormality judgment coefficient threshold, take the absolute value of the difference to obtain the usage abnormality judgment coefficient deviation value, calculate the ratio of the abnormality judgment coefficient deviation value to the abnormality judgment coefficient threshold to obtain the usage abnormality judgment coefficient deviation ratio, sum and average all the usage abnormality judgment coefficient deviation ratios corresponding to the generated inhalation behavior abnormal signal to obtain the mean of the inhalation behavior abnormal deviation ratio.

[0009] As a further solution of the present invention: the process of analyzing the stability of abnormal inhalation behavior during the monitoring period is: Obtain the number of generated large deviation signals, calculate the ratio of the number of generated large deviation signals to the number of abnormal inhalation behaviors, and obtain the ratio of large deviations; If the proportion of large deviations is compared with the threshold of large deviation proportion, if the proportion of large deviations is less than or equal to the threshold of large deviation proportion, a stable signal is generated; if the proportion of large deviations is greater than the threshold of large deviation proportion, an unstable signal is generated.

[0010] As a further solution of the present invention: the acquisition process of generating a large deviation signal is: Based on the generated high abnormality signal, the inhalation process corresponding to the generation of the abnormal inhalation behavior signal during the monitoring period is obtained, and marked as abnormal inhalation behavior; Obtaining the abnormality judgment coefficient of each abnormal inhalation behavior, summing and averaging these abnormality judgment coefficients to obtain the average of the abnormality judgment coefficients; The abnormal judgment coefficient is calculated by difference with the abnormal judgment coefficient mean, the absolute value of the difference is taken to obtain the abnormal judgment coefficient deviation value, and the abnormal judgment coefficient deviation value is compared with the abnormal judgment coefficient deviation threshold; If the abnormality judgment coefficient deviation value is greater than the abnormality judgment coefficient deviation threshold, a large deviation signal is generated.

[0011] In a second aspect, the present invention provides a control system for self-protection of an electronic atomizer output, the system comprising: Data acquisition and calculation module: when using the electronic atomizer, the user's inhalation behavior data is obtained, processed, and the abnormal use judgment coefficient is calculated; The inhalation behavior data includes the inhalation strength value of the user; Inhalation behavior judgment module: compares the abnormal use judgment coefficient with the abnormal use judgment coefficient threshold, and generates an inhalation behavior abnormality signal if the abnormal use judgment coefficient is greater than the abnormal use judgment coefficient threshold; Inhalation behavior abnormality degree assessment module: based on the generated inhalation behavior abnormality signal, calculates the abnormality degree assessment value of the monitoring period; The abnormality evaluation value is compared with the abnormality evaluation threshold, and if the abnormality evaluation value is greater than the abnormality evaluation threshold, a high abnormality signal is generated; Abnormal stability judgment module: Based on the generation of high abnormality signals, the stability of abnormal inhalation behavior during the monitoring period is analyzed.

[0012] In a third aspect, the present invention provides an electronic atomizer, on which the electronic atomizer product is provided with the electronic atomizer output self-protection control system as described above.

[0013] Beneficial effects of the present invention: (1) The present invention monitors the user's inhalation behavior data, including the inhalation force value, in real time through this embodiment, and processes the inhalation force deviation ratio and the duration ratio value to obtain the inhalation force deviation ratio and the duration ratio value, and calculates the abnormality judgment coefficient based on the obtained inhalation force deviation ratio and the duration ratio value, and uses the abnormality judgment coefficient threshold value to judge whether each inhalation behavior in the monitoring period is abnormal, so that the inhalation behavior can be judged whether it is abnormal through comprehensive calculation of the inhalation behavior, and then the user's inhalation behavior can be timely understood whether it is abnormal, which provides a strong guarantee for the safety of the user and the stability of the product; (2) After detecting the abnormal inhalation behavior signal, the present invention first calculates the abnormality evaluation value of the monitoring period, and compares the abnormality evaluation value with the preset abnormality evaluation threshold. If the abnormality evaluation value is greater than the abnormality evaluation threshold, a high abnormality signal is generated, indicating that the user's inhalation behavior has a high degree of abnormality and immediate intervention measures are required. After receiving the high abnormality signal, the abnormal inhalation behavior in the monitoring period is analyzed to determine whether the abnormal inhalation behavior is stable. If it is stable, advance regulation is performed based on the user's inhalation behavior to ensure the safe and stable operation of the electronic atomizer. (3) The present invention not only realizes accurate judgment of abnormal inhalation behavior through comprehensive calculation, but also performs output self-protection on the electronic atomizer by introducing an abnormality degree assessment mechanism and abnormal behavior analysis measures, thereby further improving the safety and stability of the electronic atomizer, providing strong protection for the safety of users and the long-term use of the product, and also demonstrating the advancement and practicality of the electronic atomizer control technology. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] The present invention will be further described below in conjunction with the accompanying drawings.

[0015] Figure 1 It is a flow chart of a control method for output self-protection of an electronic atomizer according to the present invention; Figure 2 It is a flowchart of the process of obtaining the abnormality judgment coefficient in a control method for self-protection of an electronic atomizer output of the present invention; Figure 3 The present invention is a control system block diagram of an electronic atomizer output self-protection. DETAILED DESCRIPTION

[0016] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0017] Embodiment 1: See also Figure 1 and Figure 2 As shown, a control method for self-protection of an electronic atomizer output according to an embodiment of the present invention comprises the following steps: Step 1: When using the electronic atomizer, obtain the user's inhalation behavior data, process it, and calculate the abnormal use judgment coefficient; The inhalation behavior data includes the inhalation strength value of the user; In some embodiments, when using the electronic atomizer, a monitoring period is preset, and during the monitoring period, an inhalation force value is obtained during each inhalation, and the inhalation force value is compared with a preset inhalation force value; If the inhalation force value is greater than the preset inhalation force value, an inhalation abnormality signal is generated; If the inhalation force value is less than or equal to the preset inhalation force value, a normal inhalation signal is generated; The preset inhalation force value is a critical value used to determine the magnitude of the inhalation force value, and is summarized and set by those skilled in the art based on historical experimental data; Monitor the duration of the abnormal inhalation signal in real time, perform ratio processing on the duration corresponding to the duration of the abnormal inhalation signal and the duration corresponding to the monitoring period, and obtain the duration ratio value, which is marked as ZB; Mark the time period when the abnormal inhalation signal appears as the abnormal inhalation period, obtain the inhalation force value in the abnormal inhalation period, perform difference processing on the inhalation force value and the preset inhalation force value to obtain the inhalation force difference in the abnormal inhalation period, sum and average all the inhalation force differences in the abnormal inhalation period to obtain the inhalation force difference mean, perform ratio processing on the inhalation force difference mean and the preset inhalation force value to obtain the inhalation force deviation ratio, and mark it as PC; The obtained duration ratio ZB and inhalation force deviation ratio PC are processed by the formula: , calculate the abnormal use judgment coefficient PD for each inhalation, a1 and a2 are preset proportional coefficients; It should be explained that the meaning reflected by the abnormal use judgment coefficient is: the abnormal use judgment coefficient is calculated by the inhalation force deviation ratio and the duration ratio value, that is, the larger the inhalation force deviation ratio, the larger the abnormal use judgment coefficient, the larger the deviation between the abnormal maximum value of the inhalation force and the preset inhalation force value, and the more abnormal the inhalation behavior, that is, the larger the duration ratio value, the larger the abnormal use judgment coefficient, the longer the duration of the inhalation abnormality, and the more abnormal the inhalation behavior; Step 2: Compare the abnormal use judgment coefficient with the abnormal use judgment coefficient threshold to determine whether each inhalation behavior during the monitoring period is abnormal; In some embodiments, the abnormal use judgment coefficient of each inhalation is obtained, and the abnormal use judgment coefficient of each inhalation is compared with the abnormal use judgment coefficient threshold, wherein the abnormal use judgment threshold is a critical value used to judge whether each inhalation behavior is abnormal, and is set by those skilled in the art based on historical experimental data. If the abnormal use judgment coefficient is less than or equal to the abnormal use judgment coefficient threshold, the corresponding inhalation behavior is in a normal state, and a normal inhalation behavior signal is generated; If the abnormal use judgment coefficient is greater than the abnormal use judgment coefficient threshold, the corresponding inhalation behavior is in an abnormal state, and an inhalation behavior abnormal signal is generated; The technical solution of the embodiment of the present invention is mainly as follows: this embodiment monitors the user's inhalation behavior data in real time, including the inhalation force value, and processes the inhalation force deviation ratio and the duration proportion value, calculates the use abnormality judgment coefficient based on the obtained inhalation force deviation ratio and the duration proportion value, and uses the abnormality judgment coefficient threshold to judge whether each inhalation behavior in the monitoring period is abnormal, so that through the comprehensive calculation of the inhalation behavior, it can be judged whether the inhalation behavior is abnormal, and then whether the user's inhalation behavior is abnormal can be timely understood, which provides a strong guarantee for the safety of the user and the stability of the product.

[0018] Embodiment 2: On the basis of Example 1, a control method for output self-protection of an electronic atomizer according to an embodiment of the present invention further includes the following steps: Step 3: Based on the generated abnormal inhalation behavior signal, calculate the abnormality evaluation value of the monitoring period, and evaluate the degree of abnormal inhalation behavior; In some embodiments, during the monitoring period, the total number of times the user inhales and the number of times abnormal inhalation behavior signals are generated are obtained, and the number of times abnormal inhalation behavior signals are generated is processed by ratio processing with the total number of inhalations to obtain a ratio of the number of abnormal inhalation behavior times; Obtaining a usage abnormality judgment coefficient corresponding to a generated inhalation behavior abnormal signal, performing a difference calculation between the usage abnormality judgment coefficient and a usage abnormality judgment coefficient threshold to obtain a usage abnormality judgment coefficient deviation value, performing a ratio calculation between the abnormality judgment coefficient deviation value and the abnormality judgment coefficient threshold to obtain a usage abnormality judgment coefficient deviation ratio, summing and averaging all usage abnormality judgment coefficient deviation ratios corresponding to the generated inhalation behavior abnormal signal to obtain an inhalation behavior abnormality deviation ratio mean; Substitute into the formula , calculate the abnormality evaluation value CD, where CS represents the percentage of abnormal inhalation behavior, PY represents the mean value of the abnormal deviation ratio of inhalation behavior, and s1 and s2 are preset proportional coefficients; It should be explained that the meaning reflected by the abnormality evaluation value is: the abnormality evaluation value is calculated by the ratio of the number of abnormal inhalation behaviors and the mean of the abnormal deviation ratio of inhalation behaviors, that is, the larger the ratio of the number of abnormal inhalation behaviors, the larger the abnormality evaluation value, the more the number of abnormal inhalation behaviors in the monitoring period, and the higher the abnormality degree of the user's inhalation behavior in the monitoring period, that is, the larger the mean of the abnormal deviation ratio of inhalation behaviors, the larger the abnormality evaluation value, the larger the deviation between the abnormal use judgment coefficient corresponding to the abnormal inhalation behaviors in the monitoring period and the abnormal use judgment coefficient threshold, and the higher the abnormality degree of the user's inhalation behavior in the monitoring period; Compare the abnormality evaluation value with the abnormality evaluation threshold, wherein the abnormality evaluation threshold is a critical value used to determine the abnormality of the user's inhalation behavior, and is set by a person skilled in the art based on historical experimental data; If the abnormality evaluation value is less than or equal to the abnormality evaluation threshold, it means that the abnormality of the user's inhalation behavior during the monitoring period is relatively low, and a low abnormality signal is generated; If the abnormality evaluation value is greater than the abnormality evaluation threshold, it means that the user's inhalation behavior is highly abnormal during the monitoring period, and a high abnormality signal is generated; Step 4: Based on the generation of the high abnormality signal, the stability of the abnormal inhalation behavior during the monitoring period is analyzed; In some embodiments, based on the generated high abnormality degree signal, the inhalation process corresponding to when the inhalation behavior abnormality signal is generated during the monitoring period is obtained and marked as abnormal inhalation behavior; Obtaining the abnormality judgment coefficient of each abnormal inhalation behavior, summing and averaging these abnormality judgment coefficients to obtain the average of the abnormality judgment coefficients; The abnormality judgment coefficient is respectively calculated with the abnormality judgment coefficient mean, and the absolute value of the difference is taken to obtain the abnormality judgment coefficient deviation value, and the abnormality judgment coefficient deviation value is compared with the abnormality judgment coefficient deviation threshold value, wherein the abnormality judgment coefficient deviation threshold value is set by a person skilled in the art based on historical experimental data summary; If the abnormal judgment coefficient deviation value is less than or equal to the abnormal judgment coefficient deviation threshold, it means that the abnormal judgment coefficient is slightly different from the abnormal judgment coefficient mean value, and a small deviation signal is generated; If the abnormal judgment coefficient deviation value is greater than the abnormal judgment coefficient deviation threshold, it means that the abnormal judgment coefficient is significantly different from the abnormal judgment coefficient mean value, and a large deviation signal is generated; Obtain the number of generated large deviation signals, calculate the ratio of the number of generated large deviation signals to the number of abnormal inhalation behaviors, and obtain the ratio of large deviations; If the proportion of large deviations is compared with the threshold of large deviation proportion, if the proportion of large deviations is less than or equal to the threshold of large deviation proportion, it means that there are fewer large deviation signals, and a stable signal is generated; if the proportion of large deviations is greater than the threshold of large deviation proportion, it means that there are more large deviation signals, and an unstable signal is generated; The threshold of the percentage of large deviations is set by technicians in this field based on historical experimental data. Based on the generated stable signal, it indicates that the abnormal judgment coefficient of the abnormal inhalation behavior of the user during the monitoring period is relatively stable, that is, the abnormal degree and abnormal time of inhalation are relatively stable. The electronic atomizer sends the stable signal to the control optimization module. When the user's inhalation strength value reaches the preset inhalation strength value, the electronic atomizer performs early intervention control, thereby self-protecting the output of the electronic atomizer and improving safety. The technical solution of the embodiment of the present invention is mainly as follows: after detecting the abnormal inhalation behavior signal, the embodiment first calculates the abnormality evaluation value of the monitoring period, which is calculated based on the proportion of the number of abnormal inhalation behaviors and the average value of the deviation ratio of the abnormal judgment coefficient, and can fully reflect the abnormality of the user's inhalation behavior during the monitoring period, wherein the proportion of the number of abnormal inhalation behaviors reflects the frequency of abnormal inhalation behaviors, and the average value of the deviation ratio of the abnormal judgment coefficient reveals the severity of the abnormal inhalation behaviors; By comparing the abnormality evaluation value with the preset abnormality evaluation threshold, it is possible to determine whether the abnormality of the user's inhalation behavior reaches the standard that requires further protective measures. If the abnormality evaluation value is greater than the abnormality evaluation threshold, a high abnormality signal is generated, indicating that the user's inhalation behavior has a high degree of abnormality and immediate intervention measures are required; After receiving a high abnormality signal, the abnormal inhalation behavior during the monitoring period is analyzed to determine whether the abnormal inhalation behavior is stable. If it is stable, advance regulation is performed based on the user's inhalation behavior to ensure the safe and stable operation of the electronic vaporizer.

[0019] Embodiment 3: Based on Example 1 and Example 2, please refer to Figure 3 As shown, a control system for self-protection of electronic atomizer output according to an embodiment of the present invention comprises: a data acquisition and calculation module, an inhalation behavior judgment module, an inhalation behavior abnormality degree assessment module, an abnormal stability judgment module and a cloud service platform; Data acquisition and calculation module: when using the electronic atomizer, the user's inhalation behavior data is obtained, processed, and the abnormal use judgment coefficient is calculated; The inhalation behavior data includes the inhalation strength value of the user; Inhalation behavior judgment module: compares the abnormal use judgment coefficient with the abnormal use judgment coefficient threshold to judge whether each inhalation behavior within the monitoring period is abnormal; An inhalation behavior abnormality degree evaluation module: based on the generated inhalation behavior abnormality signal, calculates the abnormality degree evaluation value of the monitoring period and evaluates the abnormality degree of the inhalation behavior; Abnormal stability judgment module: Based on the generation of high abnormality signals, the stability of abnormal inhalation behavior during the monitoring period is analyzed.

[0020] Embodiment 4: On the basis of Example 1, Example 2 and Example 3, an electronic atomizer product described in an embodiment of the present invention includes an electronic atomizer and other products provided with the electronic atomizer; The electronic atomizer product is provided with a control system for self-protection of the electronic atomizer output as described above.

[0021] The size of the above threshold is set to facilitate comparison. The size of the threshold depends on the amount of sample data and the number of bases set by technical personnel in this field for each group of sample data; for example: in the actual process, there are many groups of abnormal inhalation behavior frequency ratio values ​​and abnormal inhalation behavior deviation ratio mean values. Many groups of abnormal inhalation behavior frequency ratio values ​​and abnormal inhalation behavior deviation ratio mean values ​​are processed to obtain the abnormality level assessment values ​​of the corresponding groups. The staff evaluates the abnormality level of the inhalation behavior based on the abnormality level assessment values ​​of so many groups, thereby obtaining a corresponding relationship between the abnormality level assessment value and the abnormality level of the inhalation behavior, and then derives and divides the threshold of the abnormality level assessment value according to the abnormality level of the inhalation behavior, thereby obtaining the abnormality level assessment threshold, and compares the obtained abnormality level assessment value with the abnormality level assessment threshold, that is, completes the identification of the abnormality level of the inhalation behavior corresponding to the abnormality level assessment value.

[0022] The above is a detailed description of an embodiment of the present invention, but the content is only a preferred embodiment of the present invention and cannot be considered to limit the scope of implementation of the present invention. All equivalent changes and improvements made within the scope of the present invention should still fall within the scope of the patent coverage of the present invention.

Claims

1. A control method for self-protection of electronic atomizer output, characterized in that: The steps include: Step 1: When using the electronic atomizer, obtain the user's inhalation behavior data, process it, and calculate the abnormal use judgment coefficient; The inhalation behavior data includes the inhalation strength value of the user; Step 2: comparing the abnormal usage judgment coefficient with the abnormal usage judgment coefficient threshold, if the abnormal usage judgment coefficient is greater than the abnormal usage judgment coefficient threshold, generating an inhalation behavior abnormality signal; Step 3: Calculate the abnormality evaluation value of the monitoring period based on the generated abnormal inhalation behavior signal; The abnormality evaluation value is compared with the abnormality evaluation threshold, and if the abnormality evaluation value is greater than the abnormality evaluation threshold, a high abnormality signal is generated; Step 4: Based on the generation of a high abnormality signal, the stability of the abnormal inhalation behavior during the monitoring period is analyzed.

2. The control method for self-protection of electronic atomizer output according to claim 1, characterized in that: The acquisition process of using the abnormality judgment coefficient is as follows: Obtain the inhalation force deviation ratio PC and duration ratio ZB; The obtained duration ratio ZB and inhalation force deviation ratio PC are processed by the formula: , calculate the abnormal use judgment coefficient PD for each inhalation, and a1 and a2 are preset proportional coefficients.

3. The control method for self-protection of electronic atomizer output according to claim 2, characterized in that: The process of obtaining the duration ratio value is as follows: When using the electronic atomizer, a monitoring period is preset, and during the monitoring period, the inhalation force value of each inhalation is obtained, and the inhalation force value is compared with the preset inhalation force value; If the inhalation force value is greater than the preset inhalation force value, an inhalation abnormality signal is generated; The duration of the abnormal inhalation signal is monitored in real time, and the duration corresponding to the duration of the abnormal inhalation signal is ratioed to the duration corresponding to the monitoring period to obtain a duration ratio value, which is marked as ZB.

4. The control method for self-protection of electronic atomizer output according to claim 2, characterized in that: The process of obtaining the inhalation force deviation ratio is as follows: The time period when the abnormal inhalation signal appears is marked as the abnormal inhalation period, the inhalation force value within the abnormal inhalation period is obtained, the inhalation force value is subjected to difference processing with the preset inhalation force value to obtain the inhalation force difference within the abnormal inhalation period, all the inhalation force differences within the abnormal inhalation period are summed and averaged to obtain the mean of the inhalation force differences, the mean of the inhalation force differences is subjected to ratio processing with the preset inhalation force value to obtain the inhalation force deviation ratio, and marked as PC.

5. The control method for self-protection of electronic atomizer output according to claim 1, characterized in that: The process of obtaining the abnormality evaluation value is as follows: Obtain the percentage of abnormal inhalation behavior times and the mean of abnormal inhalation behavior deviation ratio; Substitute into the formula , the abnormality evaluation value CD is calculated, where CS represents the ratio of abnormal inhalation behavior times, PY represents the mean deviation ratio of abnormal inhalation behavior, and s1 and s2 are preset proportional coefficients.

6. A control method for self-protection of electronic atomizer output according to claim 5, characterized in that: The process of obtaining the abnormal inhalation behavior frequency ratio and the abnormal inhalation behavior deviation ratio mean is as follows: During the monitoring period, the total number of times the user inhales and the number of times abnormal inhalation behavior signals are generated are obtained, and the number of times abnormal inhalation behavior signals are generated is processed by ratio processing with the total number of inhalations to obtain the ratio of the number of abnormal inhalation behavior times; Obtain the usage abnormality judgment coefficient corresponding to the generated inhalation behavior abnormal signal, calculate the difference between the usage abnormality judgment coefficient and the usage abnormality judgment coefficient threshold, take the absolute value of the difference to obtain the usage abnormality judgment coefficient deviation value, calculate the ratio of the abnormality judgment coefficient deviation value to the abnormality judgment coefficient threshold to obtain the usage abnormality judgment coefficient deviation ratio, sum and average all the usage abnormality judgment coefficient deviation ratios corresponding to the generated inhalation behavior abnormal signal to obtain the mean of the inhalation behavior abnormal deviation ratio.

7. The method for controlling the output self-protection of an electronic atomizer according to claim 1, characterized in that: The process of analyzing the stability of abnormal inhalation behavior during the monitoring period is as follows: Obtain the number of generated large deviation signals, calculate the ratio of the number of generated large deviation signals to the number of abnormal inhalation behaviors, and obtain the ratio of large deviations; If the proportion of large deviations is compared with the threshold of large deviation proportion, if the proportion of large deviations is less than or equal to the threshold of large deviation proportion, a stable signal is generated; if the proportion of large deviations is greater than the threshold of large deviation proportion, an unstable signal is generated.

8. The method for controlling the output self-protection of an electronic atomizer according to claim 7, characterized in that: The acquisition process of generating a large deviation signal is as follows: Based on the generated high abnormality signal, the inhalation process corresponding to the generation of the abnormal inhalation behavior signal during the monitoring period is obtained, and marked as abnormal inhalation behavior; Obtaining the abnormality judgment coefficient of each abnormal inhalation behavior, summing and averaging these abnormality judgment coefficients to obtain the average of the abnormality judgment coefficients; The abnormal judgment coefficient is calculated by difference with the abnormal judgment coefficient mean, the absolute value of the difference is taken to obtain the abnormal judgment coefficient deviation value, and the abnormal judgment coefficient deviation value is compared with the abnormal judgment coefficient deviation threshold; If the abnormality judgment coefficient deviation value is greater than the abnormality judgment coefficient deviation threshold, a large deviation signal is generated.

9. A control system for self-protection of electronic atomizer output, characterized in that: The system is used to execute the method described in any one of claims 1 to 8, and the system comprises: Data acquisition and calculation module: when using the electronic atomizer, the user's inhalation behavior data is obtained, processed, and the abnormal use judgment coefficient is calculated; The inhalation behavior data includes the inhalation strength value of the user; Inhalation behavior judgment module: compares the abnormal use judgment coefficient with the abnormal use judgment coefficient threshold, and generates an abnormal inhalation behavior signal if the abnormal use judgment coefficient is greater than the abnormal use judgment coefficient threshold; Inhalation behavior abnormality degree assessment module: based on the generated inhalation behavior abnormality signal, calculates the abnormality degree assessment value of the monitoring period; The abnormality evaluation value is compared with the abnormality evaluation threshold, and if the abnormality evaluation value is greater than the abnormality evaluation threshold, a high abnormality signal is generated; Abnormal stability judgment module: Based on the generation of high abnormality signals, the stability of abnormal inhalation behavior during the monitoring period is analyzed.

10. An electronic atomizer product, characterized in that: The electronic atomizer product is provided with a control system for self-protection of the electronic atomizer output as claimed in claim 9.

Images